PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) announced the appointment of Steve Gavel as Chief Commercial Officer, ...

Also! In honor of World CRISPR Day (yesterday, but close enough), we have a very special 50% discount rate if you sign up for ...

Companies working on new medicines to treat obesity and a new approach to using artificial intelligence in science labs are ...

Investors have grown more cautious about putting their money into the inherently unpredictable drug development industry.